This proof-of-concept study aims to measure the feasibility, acceptability, and potential benefits of a novel multimodal approach: the micro-choice-based intervention.
Official registry: https://clinicaltrials.gov/study/NCT07726082 · University Hospital, Basel, Switzerland · enrollment listed as 24
This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
If you join, the listed intervention(s) are Micro-choice-based intervention. The registry lists allocation as na. This proof-of-concept study aims to measure the feasibility, acceptability, and potential benefits of a novel multimodal approach: the micro-choice-based intervention.
They plan to enroll about 24 people at Basel. Taking part typically means following a program (exercise, therapy, diet, or an app) plus check-ins.
Micro-choice-based Intervention for Multicausal Fatigue: Proof of Concept Study
Interventions: Micro-choice-based intervention
Primary outcome (registry wording): Retention rate
Katrin Bopp, Dr.
Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.
LIINC is a study of volunteers who were previously infected with SARS-CoV-2 (also known as novel coronavirus or COVID-19) who have recovered from acute infection. The study is designed to provide a specimen bank of samples with carefully characterized clinical data.
NCT04362150 · Official ClinicalTrials.gov record · University of California, San Francisco
We will enroll long-COVID patients with cognitive impairments. All patients will receive DAOIB for 24 weeks.
NCT05764538 · Official ClinicalTrials.gov record · Chang Gung Memorial Hospital
This study aims to verify the how well it works/effectiveness of treatment with transcranial direct current stimulation (TDCS) in patients with Long Covid who experience headaches, migraines, and chronic pain, such as arthralgia and myalgia, as well as sleep problems. Transcranial direct current stimulation is used in the field of Physiotherapy and Rehabilitation, with results that have proven to be effective for treating patients suffering from symptoms like migraines, headaches, chronic pain, fibromyalgia, or chronic neuropathic pain and insomnia.
NCT05780450 · Official ClinicalTrials.gov record · Fundación Universidad Católica de Valencia San Vicente Mártir
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary